MENU

ANPCY Stock ANGLE (ANPCY, $0.82) was a top loser yesterday, falling -17.63%

A.I.dvisor
at Tickeron.com
Loading...
ANPCY - ANGLE plc
Tickeron

Loading...

Price: $0.8237
Daily change: -$0.1763 (-17.63%)
Daily volume: 2.7K
Capitalization: $30.2M
Industry: Medical Specialties
ANGLE (ANPCY, $0.82) was a top loser yesterday, declining -1 to $0.82 per share. Of the 87 stocks analyzed in the Medical Specialties Industry, of them (6) exhibited an Uptrend while of them (3) were in a Downtrend.

ANPCY in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 03, 2025

ANPCY broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 19 similar instances where the stock broke above the upper band. In of the 19 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ANPCY moved out of overbought territory on September 04, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Aroon Indicator for ANPCY entered a downward trend on August 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on August 18, 2025. You may want to consider a long position or call options on ANPCY as a result. In of 57 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ANPCY just turned positive on August 19, 2025. Looking at past instances where ANPCY's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

ANPCY moved above its 50-day moving average on August 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ANPCY crossed bullishly above the 50-day moving average on September 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ANPCY advanced for three days, in of 19 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.072) is normal, around the industry mean (10.423). P/E Ratio (0.000) is within average values for comparable stocks, (140.836). ANPCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.686). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (6.317) is also within normal values, averaging (9.722).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ANPCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANPCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ANPCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
10 Nugent Road
Phone
+44 1483343434
Employees
170
Web
https://www.angleplc.com